GIP and obesity disorder: The investigation of combinations involving GLP-1, gastric inhibitory polypeptide (GIP), islet amyloid polypeptide, glucagon, and leptin has revealed their potential to enhance weight loss in adults with obesity and type 2 diabetes [51].